These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15111988)

  • 1. Variable drug metabolism genes in Arab population.
    Bu R; Gutiérrez MI; Al-Rasheed M; Belgaumi A; Bhatia K
    Pharmacogenomics J; 2004; 4(4):260-6. PubMed ID: 15111988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood group phenotype distribution in Saudi Arabs.
    Abdelaal MA; Anyaegbu CC; al Sobhi EM; al Baz NM; Hodan K
    Afr J Med Med Sci; 1999; 28(3-4):133-5. PubMed ID: 11205816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic gene polymorphism frequencies in control populations.
    Garte S; Gaspari L; Alexandrie AK; Ambrosone C; Autrup H; Autrup JL; Baranova H; Bathum L; Benhamou S; Boffetta P; Bouchardy C; Breskvar K; Brockmoller J; Cascorbi I; Clapper ML; Coutelle C; Daly A; Dell'Omo M; Dolzan V; Dresler CM; Fryer A; Haugen A; Hein DW; Hildesheim A; Hirvonen A; Hsieh LL; Ingelman-Sundberg M; Kalina I; Kang D; Kihara M; Kiyohara C; Kremers P; Lazarus P; Le Marchand L; Lechner MC; van Lieshout EM; London S; Manni JJ; Maugard CM; Morita S; Nazar-Stewart V; Noda K; Oda Y; Parl FF; Pastorelli R; Persson I; Peters WH; Rannug A; Rebbeck T; Risch A; Roelandt L; Romkes M; Ryberg D; Salagovic J; Schoket B; Seidegard J; Shields PG; Sim E; Sinnet D; Strange RC; Stücker I; Sugimura H; To-Figueras J; Vineis P; Yu MC; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1239-48. PubMed ID: 11751440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
    Siraj AK; Ibrahim M; Al-Rasheed M; Abubaker J; Bu R; Siddiqui SU; Al-Dayel F; Al-Sanea O; Al-Nuaim A; Uddin S; Al-Kuraya K
    BMC Med Genet; 2008 Jul; 9():61. PubMed ID: 18601742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymorphisms of drug-metabolizing enzymes genes in a Han Chinese population].
    Liu L; Yang L; Zhang YC; Ai XF; Wang JX; Xiao ZJ
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2675-81. PubMed ID: 20137266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP3A4*1B and NAT2*14 alleles in a native African population.
    Cavaco I; Reis R; Gil JP; Ribeiro V
    Clin Chem Lab Med; 2003 Apr; 41(4):606-9. PubMed ID: 12747609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of glutathione-S-transferase null-M1 and null-T1 genotypes among the Turabah population in Saudi Arabia.
    Mansour AA; Saleh OM; Askar T; Salim AM; Mergani A
    Genet Mol Res; 2015 Dec; 14(4):16863-71. PubMed ID: 26681032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans.
    Rosenberg N; Murata M; Ikeda Y; Opare-Sem O; Zivelin A; Geffen E; Seligsohn U
    Am J Hum Genet; 2002 Mar; 70(3):758-62. PubMed ID: 11781870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indigenous Arabs have an intermediate frequency of a Neanderthal-derived COVID-19 risk haplotype compared with other world populations.
    Mineta K; Goto K; Gojobori T; Alkuraya FS
    Clin Genet; 2021 Mar; 99(3):484-485. PubMed ID: 33245148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention.
    Loktionov A; Moore W; Spencer SP; Vorster H; Nell T; O'Neill IK; Bingham SA; Cummings JH
    Cancer Detect Prev; 2002; 26(1):15-22. PubMed ID: 12088198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.
    Solus JF; Arietta BJ; Harris JR; Sexton DP; Steward JQ; McMunn C; Ihrie P; Mehall JM; Edwards TL; Dawson EP
    Pharmacogenomics; 2004 Oct; 5(7):895-931. PubMed ID: 15469410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes.
    Skjelbred CF; Svendsen M; Haugan V; Eek AK; Clausen KO; Kure EH; Tuimala JT; Svendsen MV; Norppa H; Hansteen IL
    Carcinogenesis; 2011 Mar; 32(3):399-405. PubMed ID: 21097530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes.
    Makeeva O; Stepanov V; Puzyrev V; Goldstein DB; Grossman I
    Pharmacogenomics; 2008 Jul; 9(7):847-68. PubMed ID: 18597650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype frequencies of polymorphic GSTM1, GSTT1, and cytochrome P450 CYP1A1 in Mexicans.
    Montero R; Araujo A; Carranza P; Mejía-Loza V; Serrano L; Albores A; Salinas JE; Camacho-Carranza R
    Hum Biol; 2007 Jun; 79(3):299-312. PubMed ID: 18078203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
    Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
    Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population.
    Mishra DK; Kumar A; Srivastava DS; Mittal RD
    Asian Pac J Cancer Prev; 2004; 5(4):362-5. PubMed ID: 15546237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore.
    Chowbay B; Zhou S; Lee EJ
    Drug Metab Rev; 2005; 37(2):327-78. PubMed ID: 15931768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.